Table 2.

Annual health and economic burden of postpartum hemorrhage in Senegal comparing baseline to no substandard uterotonics

	Baseline	IQR		No substandard uterotonics	Difference	IQR of difference		Diff %
Health outcomes
PPH ≥ 500 ml	86,542	84,046	88,726	81,540	-5,002	-5,817	-4,137	-6%
PPH ≥ 1,000 ml	21,152	20,429	21,871	19,769	-1,383	-1,726	-1,023	-7%
PPH ≥ 500 ml diagnosed	22,306	21,521	23,041	20,275	-2,031	-2,429	-1,606	-9%
PPH ≥ 1,000 ml diagnosed	6,386	6,137	6,657	5,823	-563	-743	-366	-9%
Additional uterotonic treatment	35,250	34,035	36,437	29,331	-5,918	-6,493	-5,240	-17%
Blood transfusions	14,408	13,846	14,938	9,643	-4,765	-5,156	-4,359	-33%
Deaths due to PPH	447	411	480	418	-28	-74	17	-6%
Economic outcomes
Total economic burden of PPH	$19,499,322	$17,915,171	$20,943,962	$18,221,486	-1,277,836	-2,986,716	494,788	-7%
Total OOP costs public	$1,774,990	$956,429	$2,103,519	$1,615,355	-159,634	-188,828	-80,720	-9%
Total OOP costs private	$833,766	$702,163	$939,894	$787,498	-46,268	-95,959	3,656	-6%
Long term productivity loss	$16,890,566	$15,557,186	$18,150,050	$15,818,633	-1,071,933	-2,808,936	648,216	-6%

Diff = Difference; IQR = Interquartile range; OOP: out-of-pocket; PPH: postpartum hemorrhage; USD: United States Dollars